Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 45 citing articles:

ISG15 and ISGylation in Human Diseases
Oygul Mirzalieva, Meredith Juncker, Joshua Schwartzenburg, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 538-538
Open Access | Times Cited: 65
ISG15 in cancer: Beyond ubiquitin-like protein
Hye Gyeong Han, Hye Won Moon, Young Joo Jeon
Cancer Letters (2018) Vol. 438, pp. 52-62
Closed Access | Times Cited: 82
The diverse repertoire of ISG15: more intricate than initially thought
Ji An Kang, Yoon Jung Kim, Young Joo Jeon
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 11, pp. 1779-1792
Open Access | Times Cited: 38
STUB1/CHIP: New insights in cancer and immunity
Yongshuo Liu, Honghong Zhou, Xiaolong Tang
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115190-115190
Open Access | Times Cited: 20
The Functional Roles of ISG15/ISGylation in Cancer
Yuan Yin, Hai Qin, Huilong Li, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1337-1337
Open Access | Times Cited: 19
Interferon stimulated gene 15 (ISG15) in cancer: An update
Hong-My Nguyen, Shreyas Gaikwad, Mariam Oladejo, et al.
Cancer Letters (2023) Vol. 556, pp. 216080-216080
Open Access | Times Cited: 17
More than Meets the ISG15: Emerging Roles in the DNA Damage Response and Beyond
Zac Sandy, Isabelle Cristine da Costa, Christine K. Schmidt
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1557-1557
Open Access | Times Cited: 46
Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation
Jia Sun, Jing Ying Yan, Huaiyu Qiao, et al.
Oncogene (2019) Vol. 39, Iss. 3, pp. 546-559
Closed Access | Times Cited: 44
ISGylation in Innate Antiviral Immunity and Pathogen Defense Responses: A Review
Mengdi Zhang, Jingxian Li, Haiyan Yan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 38
Chaperone-assisted E3 ligase CHIP: A double agent in cancer
Sunny Kumar, Malini Basu, Mrinal K. Ghosh
Genes & Diseases (2021) Vol. 9, Iss. 6, pp. 1521-1555
Open Access | Times Cited: 31
ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell‐like features in cisplatin‐resistant ovarian cancer
Qi Zhang, Jiamei Wang, Huaiyu Qiao, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 9, pp. 4395-4407
Open Access | Times Cited: 29
ISG15 deficiency restricts HIV-1 infection
Denise Jurczyszak, Lara Manganaro, Sofija Buta, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 3, pp. e1010405-e1010405
Open Access | Times Cited: 21
HERC5/ISG15 Enhances Glioblastoma Stemness and Tumor Progression by mediating SERBP1protein stability
Zhixiao Li, Rongjun Qian, Mengda Li, et al.
NeuroMolecular Medicine (2025) Vol. 27, Iss. 1
Closed Access
ISGylation: is our genome yearning for such a modification?
Zheng Chen, Zheng Li, Ying Wang, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
E3 ligase HERC5-catalyzed UGDH isgylation promotes SNAI1-mediated tumor metastasis and cisplatin resistance in oral squamous cell carcinoma
Xu Zhang, Fayu Liu, Qigen Fang, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
Ubiquitin-like modification dependent proteasomal degradation and disease therapy
Tiantian Wang, Jie Jiang, Xue Zhang, et al.
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 3
UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells
Sanam Sane, Andre Hafner, Rekha Srinivasan, et al.
Molecular Oncology (2018) Vol. 12, Iss. 10, pp. 1753-1777
Open Access | Times Cited: 32
ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells
Jiamei Wang, Bao-Qin Liu, Qi Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2020) Vol. 1867, Iss. 4, pp. 118647-118647
Open Access | Times Cited: 27
Regulation of E3 ubiquitin ligases by homotypic and heterotypic assembly
Vishnu Balaji, Thorsten Hoppe
F1000Research (2020) Vol. 9, pp. 88-88
Open Access | Times Cited: 25
Induced TRIM21 ISGylation by IFN-β enhances p62 ubiquitination to prevent its autophagosome targeting
Jie Jin, Xianbin Meng, Yi Huo, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 7
Open Access | Times Cited: 22
The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases
Maryam Rahimi‐Tesiye, Mona Zaersabet, Sajad Salehiyeh, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188954-188954
Closed Access | Times Cited: 8
Proteasome Levels and Activity in Pregnancies Complicated by Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Thrombocytopenia (HELLP) Syndrome
Kathryn Berryman, Catalin S. Buhimschi, Guomao Zhao, et al.
Hypertension (2019) Vol. 73, Iss. 6, pp. 1308-1318
Open Access | Times Cited: 20
Deleting key autophagy elongation proteins induces acquirement of tumor-associated phenotypes via ISG15
EunBin Kong, Hag Dong Kim, Joon Kim
Cell Death and Differentiation (2020) Vol. 27, Iss. 8, pp. 2517-2530
Open Access | Times Cited: 20
A Critical Role for ISGylation, Ubiquitination and, SUMOylation in Brain Damage: Implications for Neuroprotection
Venkata Prasuja Nakka, Abdul Qadeer Mohammed
Neurochemical Research (2020) Vol. 45, Iss. 9, pp. 1975-1985
Closed Access | Times Cited: 20
Transcriptional corepressor activity of CtBP1 is regulated by ISG15 modification
Yun Hwan Lim, Yoon Jin Park, Ji‐Eun Lee, et al.
Animal Cells and Systems (2024) Vol. 28, Iss. 1, pp. 66-74
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top